DI BIASE, LUIGI
 Distribuzione geografica
Continente #
EU - Europa 15.262
NA - Nord America 13.405
AS - Asia 12.989
SA - Sud America 2.581
AF - Africa 162
Continente sconosciuto - Info sul continente non disponibili 91
OC - Oceania 14
Totale 44.504
Nazione #
US - Stati Uniti d'America 13.172
CN - Cina 5.712
IE - Irlanda 5.280
UA - Ucraina 4.484
SG - Singapore 3.015
BR - Brasile 2.181
RU - Federazione Russa 1.700
SE - Svezia 1.694
HK - Hong Kong 1.398
FI - Finlandia 842
VN - Vietnam 840
TR - Turchia 834
IN - India 744
DE - Germania 344
IT - Italia 285
GB - Regno Unito 267
AR - Argentina 166
CA - Canada 100
EU - Europa 85
BD - Bangladesh 83
MX - Messico 82
EC - Ecuador 68
AT - Austria 65
ID - Indonesia 57
IQ - Iraq 54
ZA - Sudafrica 53
PL - Polonia 51
CO - Colombia 48
FR - Francia 47
RO - Romania 43
JP - Giappone 33
MA - Marocco 32
PY - Paraguay 30
UZ - Uzbekistan 30
NL - Olanda 28
BE - Belgio 27
VE - Venezuela 27
CL - Cile 26
PK - Pakistan 26
SA - Arabia Saudita 25
TN - Tunisia 21
ES - Italia 18
EG - Egitto 16
PE - Perù 13
UY - Uruguay 13
AU - Australia 12
AZ - Azerbaigian 11
CZ - Repubblica Ceca 11
DO - Repubblica Dominicana 11
DZ - Algeria 11
KZ - Kazakistan 11
OM - Oman 11
IL - Israele 10
IR - Iran 10
JO - Giordania 10
AE - Emirati Arabi Uniti 9
GR - Grecia 9
NP - Nepal 9
CR - Costa Rica 8
JM - Giamaica 8
BG - Bulgaria 7
KR - Corea 7
LB - Libano 7
PT - Portogallo 7
AL - Albania 6
BO - Bolivia 6
HN - Honduras 6
KE - Kenya 6
LT - Lituania 6
PA - Panama 6
PH - Filippine 6
PS - Palestinian Territory 6
ET - Etiopia 5
HR - Croazia 5
HU - Ungheria 5
KW - Kuwait 5
BH - Bahrain 4
CH - Svizzera 4
DK - Danimarca 4
GA - Gabon 4
LV - Lettonia 4
RS - Serbia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CI - Costa d'Avorio 3
GT - Guatemala 3
GY - Guiana 3
LU - Lussemburgo 3
MY - Malesia 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
BA - Bosnia-Erzegovina 2
BW - Botswana 2
CU - Cuba 2
GE - Georgia 2
KH - Cambogia 2
MD - Moldavia 2
MK - Macedonia 2
ML - Mali 2
NG - Nigeria 2
Totale 44.475
Città #
Dublin 5.272
Jacksonville 3.168
Nanjing 1.692
Hong Kong 1.391
Singapore 1.233
Chandler 973
Dearborn 908
Nyköping 888
Wilmington 854
Beijing 706
Ashburn 665
Nanchang 662
Santa Clara 658
Princeton 636
San Mateo 554
Moscow 460
Dallas 382
Shenyang 334
Ho Chi Minh City 305
Hebei 287
Tianjin 269
Kunming 245
Helsinki 206
Jiaxing 204
São Paulo 186
Hanoi 152
Changsha 151
Ann Arbor 150
Hangzhou 149
Boardman 146
New York 144
Des Moines 116
Jinan 107
Guangzhou 98
Hilden 92
Los Angeles 78
Changchun 75
Zhengzhou 75
Shanghai 72
Ningbo 71
Woodbridge 68
Dong Ket 67
Lanzhou 67
Stevenage 67
The Dalles 61
Nuremberg 59
Rio de Janeiro 59
Belo Horizonte 49
Norwalk 41
Porto Alegre 40
Taizhou 39
Timisoara 39
Warsaw 38
Curitiba 36
Mexico City 32
Orange 32
Haiphong 31
Brasília 30
Vienna 29
Biên Hòa 28
Fuzhou 28
San Francisco 27
Tashkent 27
Campinas 26
Da Nang 26
Redwood City 26
Brooklyn 25
Council Bluffs 25
Toronto 25
Chicago 24
Guayaquil 24
Wuhan 24
Milan 23
Quito 23
Tokyo 23
Montreal 22
Manaus 21
Thái Bình 20
Baghdad 19
Dhaka 19
Johannesburg 19
Salvador 19
Boston 18
Guarulhos 18
Jinhua 18
Volta Redonda 18
Hanover 17
Hefei 17
London 17
Asunción 16
Brussels 16
Munich 16
Recife 16
Cape Town 15
Caxias do Sul 15
Ninh Bình 15
Rome 15
Stockholm 15
Washington 15
Auburn Hills 14
Totale 26.532
Nome #
2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing 142
3-D Assessment of Myocardial Ablation Lesions using Ultrasound-guided Spectroscopic Photoacoustic Imaging 133
QRS duration predicts death and hospitalization among patients with atrial fibrillation irrespective of heart failure: evidence from the AFFIRM study 123
A systematic review and meta-analysis of the association between implantable cardioverter-defibrillator shocks and long-term mortality 122
Ablation for longstanding permanent atrial fibrillation: results from a randomized study comparing three different strategies 116
[Takotsubo cardiomyopathy: current evidence from observational studies and pathophysiological background] 112
Is a dual-sensor pacemaker appropriate in patients with sino-atrial disease? Results from the DUSILOG Study 111
Feasibility of combined unipolar and bipolar voltage maps to improve sensitivity of endomyocardial biopsy 111
Near zerO fluoroscopic exPosure during catheter ablAtion of supRavenTricular arrhYthmias: the NO-PARTY multicentre randomized trial 111
Statins do not reduce atrial fibrillation recurrence after pulmonary vein isolation in postmenopausal females 110
2D and 3D TEE evaluation of an early Reopening of the LARIAT Epicardial left atrial appendage closure device. 110
Amiodarone increases the AF termination during ablation but reduces the long term success rate of patients undergoing ablation of long-standing persistent atrial fibrillation: preliminary results from the speculate study 108
Ablation of Stable VTs Versus Substrate Ablation in Ischemic Cardiomyopathy the VISTA Randomized Multicenter Trial 108
Pulmonary vein antrum isolation, atrioventricular junction ablation, and antiarrhythmic drugs combined with direct current cardioversion: survival rates at 7 years follow-up 106
Preferential Association of Biomarkers With Non-paroxysmal Atrial Fibrillation Indicates The Role of Inflammation in Persistence of the Arrhythmia 106
Ablation of atrial arrhythmias in heart failure 106
Mortality of Heart Failure Patients After Cardiac Resynchronization Therapy: Identification of Predictors 105
Ablation as First-Line Therapy for Atrial Fibrillation 105
Esophageal Capsule Endoscopy After Radiofrequency Catheter Ablation for Atrial Fibrillation Documented Higher Risk of Luminal Esophageal Damage With General Anesthesia as Compared With Conscious Sedation 104
Atrial fibrillation termination mode comparing three common ablation strategies for permanent atrial fibrillation: results from a randomized study. 104
A Practical ECG Criterion to Unmask Left Accessory AV Connections in Patients With Subtle Preexcitation 104
Catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia 103
Ablation for Atrial Fibrillation 103
Impact of gender on outcomes after atrial fibrillation ablation 103
Outcomes of atrioesophageal fistula following catheter ablation of atrial fibrillation treated with surgical repair versus esophageal stenting 102
Endo-epicardial ablation of ventricular arrhythmias in the left ventricle with the Remote Magnetic Navigation System and the 3.5-mm open irrigated magnetic catheter: results from a large single-center case-control series 101
Aggressive Life-style Modifications Facilitate Arrhythmia-free Survival in Atrial Fibrillation Patients With Coexistent Metabolic Syndrome and Sleep Apnea Having Sporadic Recurrence Following First Ablation Procedure Sanghamitra Mohanty, Prasant Mohanty, Lui 101
Outcomes of Atrio-Esophageal Fistula Following Catheter Ablation of Atrial Fibrillation Treated With Esophageal Stent: a Case Series 101
Pacing site and bradycardia dependent retrograde conduction block over an atrioventricular accessory pathway 100
Validation of the Framingham Heart Study and CHARGE-AF Risk Scores for Atrial Fibrillation in Hispanics, African-Americans, and Non-Hispanic Whites 100
Ablating the Posterior Heart: Cardioesophageal Fistula Complicating Radiofrequency Ablation in the Coronary Sinus 99
Chronicling the evolution of catheter ablation for atrial fibrillation and ventricular tachycardia. 98
Prognostic value of automatically detected early repolarization 98
Silent Cerebral Events/Lesions Related to Atrial Fibrillation Ablation: A Clinical Review 98
Women have a Two-fold Higher Risk for Developing Cardiac Tamponade during AF Ablation Procedures: Results from a Multicenter International Survey in 27,249 Cases. 98
Robotic navigation for catheter ablation: benefits and challenges 98
Cerebrovascular Complications Related to Atrial Fibrillation Ablation and Strategies for Periprocedural Stroke Prevention 97
Visual, tactile, and contact force feedback: which one is more important for catheter ablation? Results from an in vitro experimental study. 97
Dabigratan Has a Higher Risk of Left Atrial Appendage Thrombus Formation in Patients With Af When Compared to Warfarin and Rivaroxaban 97
Pulmonary Vein Isolation to Reduce Future Risk of Atrial Fibrillation in Patients Undergoing Typical Flutter Ablation: Results from a Randomized Pilot Study (REDUCE AF) 97
Atrial fibrillation ablation using a robotic catheter remote control system: initial human experience and long-term follow-up results 96
Ventricular Tachycardia Ablation—For Whom, When, and How? 96
[Catheter ablation of atrial fibrillation: an update from the most important trials]. 96
Management of refractory atrial fibrillation post surgical ablation. 96
Reply: A Prima Vista Ablation of Ventricular Tachycardia: Should We Abandon the Mapping of VT? 96
Dynamic changes of QTc interval and prognostic significance in takotsubo (stress) cardiomyopathy 96
Mechanical and electrical alternans in heart failure patients implanted with biventricular pacemakers. 95
Early safety and efficacy of percutaneous left atrial appendage suture ligation: results from the U.S. transcatheter LAA ligation consortium 95
Safety and feasibility of levosimendan administration in Takotsubo Cardiomyopathy: A case series 94
How to Ablate Long-Standing, Persistent Atrial Fibrillation Using a Step-Wise Approach (The Natale Approach) 94
Reverse remodelling induced by resynchronization therapy is associated to renin-angiotensin system activity improvement 93
Metodo di mappaggio ed ablazione transcatetere di aritmie ventricolari attraverso il seno di Valsalva descrizione di due casi. 93
OPEN IRRIGATION CATHETERS GENERATE HIGHER ESOPHAGEAL TISSUE TEMPERATURES THAN STANDARD 8MM TIP CATHETERS WHEN ABLATING WITHIN THE LEFT ATRIUM. 93
DOES TERMINATION OF ATRIAL FIBRILLATION DURING ABLATION OF LONG STANDING PERSISTENT ATRIAL FIBRILLATION PREDICT THE OUTCOME AT FOLLOW-UP? RESULTS FROM A PROSPECTIVE RANDOMIZED STUDY 93
Prevalence and Management of Atrial Fibrillation in Middle-Aged/Older Athletes 92
Effect of periprocedural amiodarone on procedure outcome in longstanding persistent atrial fibrillation undergoing extended pulmonary vein antrum isolation: Results from a randomized study (SPECULATE) 92
EFFECT OF CATHETER ABLATION ON THE CLINICAL COURSE OF MIGRAINE IN ATRIAL FIBRILLATION PATIENTS WITH OR WITHOUT PRE-EXISTENT MIGRAINE: RESULTS FROM A PROSPECTIVE STUDY (CONFIRM) 92
Association of pretreatment with angiotensin-converting enzyme inhibitors with improvement in ablation outcome in atrial fibrillation patients with low left ventricular ejection fraction 92
Biomarkers of myocardial injury with different energy sources for atrial fibrillation catheter ablation. 91
Pulmonary vein calcification by EBCT in patients with drug refractory nonvalular atrial fibrillation 91
Is ablation of atrial fibrillation in patients with chronic left atrial appendage thrombus safe? 91
Hybrid strategies for Ablation of permanent AF as an Adjunct to PVI: implications of targeting AF NEST in sinus Rhythm and CFAE in AF. 91
Catheter ablation of ventricular arhhythmias with the remote magnetic navigation system and the 3.5 mm openirrigated magnetic catheter: results from a large single center series 91
Current and previous smoking increases mortality in patients on cardiac resynchronization therapy 91
Catheter Ablation for Long-Standing Persistent Atrial Fibrillation 91
Acute and early outcomes of focal impulse and rotor modulation (FIRM)-guided rotors-only ablation in patients with nonparoxysmal atrial fibrillation 91
Remote magnetic navigation for atrial fibrillation ablation: is ‘As Good as Manual’ good enough 90
Sviluppo e valutazione di un simulatore di procedura di cateterismo transattale in elettrofisiologia. 90
La crioablazione nel trattamento delle aritmie correlate a via accessoria antero e medio-settale: risultati acuti ed a lungo termine. 90
Safety and efficacy in females undergoing pulmonary vein isolation. 90
Role of intracardiac echocardiography in atrial fibrillation ablation 90
Baseline Neutrophil/Lymphocyte Ratio Predicts Recurrences After Radiofrequency Catheter Ablation: Results From Prospective Study on Paroxysmal Atrial Fibrillation 90
Impact of Systematic Isolation of Superior Vena Cava in Addition to Pulmonary Vein Antrum Isolation on the Outcome of Paroxysmal, Persistent, and Permanent Atrial Fibrillation Ablation: Results from a Randomized Study 89
Real Time Monitoring of Tip Electrode-Tissue Orientation and Contact Force: Optimizing Accuracy and Safety of Mapping and Ablation Procedures. 89
Impact of cardiac resynchronization therapy on the severity of mitral regurgitation 89
Graded effect left ventricular ejection fraction on outcomes of ventricular tachycardia ablation: a multicenter experience 89
Feasibility and Safety of Uninterrupted Rivaroxaban in Patients Undergoing Radiofrequency Ablation for Long Standing Persistent Atrial Fibrillation 89
Zero Fluoroscopy Ablation of Atrial Fibrillation: A Safety and Feasibility Study 89
The Role of Cardiac Imaging in Stroke Prevention 88
Ablation of perimitral flutter following catheter ablation of atrial fibrillation: impact on outcomes from a randomized study. 88
Implicazioni neuroautonomiche della ablazione transcatetere di fibrillazione atriale 88
Comparison of Radiation Doses and Procedures Times in Patients Undergoing AF Ablation with the Hansen Robotic System with a Conventional Approach 88
Ablation for atrial fibrillation: termination of atrial fibrillation is not the endpoint. Contemporary debates and Controversies in Cardiac Electrophysiology, Part II 88
Influence of Hospital Characteristics and Operator Volume on Adverse Outcomes of Atrial Fibrillation Ablation 88
Novel Single-Nucleotide Polymorphisms Predict Inverse Association With Non-Pulmonary Vein Triggers in Patients With Paroxysmal Atrial Fibrillation: Results From a Prospective Study (DECAF) 88
Left Atrial Appendage Occlusion Device and Novel Oral Anticoagulants versus Warfarin for Stroke Prevention in Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Control Trials 88
Novel association of polymorphic genetic variants with predictors of outcome of catheter ablation in atrial fibrillation: new directions from a prospective study (DECAF) 88
Hybrid Procedure (Endo/Epicardial) versus Standard Manual Ablation in Patients Undergoing Ablation of Longstanding Persistent Atrial Fibrillation: Results from a Single Center 88
Remote magnetic with open-irrigated catheter vs. manual navigation for ablation of atrial fibrillation: a systematic review and meta-analysis. 88
Pulmonary Vein Total Occlusion Following Catheter Ablation for Atrial Fibrillation: Clinical implications after long term follow up 87
Assenza di eventi cardiaci maggiori in pazienti che presentano rimodellamento inverso e riduzione dei markers infiammatorii al follow-up dopo impianto di pacemaker biventricolare per scompenso cardiaco. 87
Identification of Predictors for Future Stroke in Patients with a Chads Score of 0. 87
Ablation of atrial fibrillation under therapeutic INR reduces periprocedural complications: time to change the guidelines? 87
Nonfluoroscopic mapping reduces radiation exposure in ablation of atrial fibrillation. 87
Systematic fluoroscopic and electrical assessment of implantable cardioverter-defibrillator patients implanted with silicone-polyurethane copolymer (Optim™) coated leads. 87
Apixaban is Dear to Me, but Dearer Still is Warfarin 87
Exploring the potential role of catheter ablation in patients with asymptomatic atrial fibrillation. Should we move away from symptom relief? 87
Age-dependent impact of fluoroscopic radiation on the gender of off-spring: An international survey of cardiologists 87
Intracardiac Echo Findings Post Atrial Fibrillation Ablation Are an Important Predictor of Late Pericardial Effusion 87
IMPACT OF A NEW OPEN IRRIGATED CATHETER ON THE RISK OF FLUID OVERLOAD AFTER ABLATION OF LONG STANDING PERSISTENT ATRIAL FIBRILLATION: RESULTS FROM A PROSPECTIVE RANDOMIZED STUDY 87
Totale 9.669
Categoria #
all - tutte 259.490
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 259.490


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.650 0 0 0 0 0 164 641 428 641 685 17 74
2021/20222.825 547 4 6 3 271 74 84 274 357 333 149 723
2022/20238.903 981 144 295 327 308 559 12 382 5.654 57 81 103
2023/2024815 149 49 48 34 74 216 30 36 15 11 9 144
2024/20257.419 301 40 94 105 83 1.071 628 396 2.824 641 489 747
2025/20265.985 639 729 1.554 2.624 273 166 0 0 0 0 0 0
Totale 45.447